0001555280-24-000075.txt : 20240208 0001555280-24-000075.hdr.sgml : 20240208 20240208163302 ACCESSION NUMBER: 0001555280-24-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240206 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Heidi C. CENTRAL INDEX KEY: 0001567828 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 24609594 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wk-form4_1707427970.xml FORM 4 X0508 4 2024-02-06 0 0001555280 Zoetis Inc. ZTS 0001567828 Chen Heidi C. C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Executive Vice President 0 Restricted Stock Unit 2024-02-06 4 A 0 1803 0 A Common Stock 1803 1803 D Restricted Stock Unit Common Stock 2123.8671 2123.8671 D Restricted Stock Unit Common Stock 3781.6999 3781.6999 D Stock Option 196.14 2024-02-06 4 A 0 6936 0 A Common Stock 6936 6936 D Stock Option 162.07 Common Stock 7834 7834 D Stock Option Common Stock 39737 39737 D Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. The RSUs vest as follows: 2,108.6777 RSUs will vest on February 10, 2024; and 1,673.0222 RSUs will vest on February 8, 2025. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024. Each option expires on the tenth anniversary of the date of grant. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 8, 2023. Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option; 6,477 options granted February 8, 2022 at an exercise price of $201.30 per option. Each option vests on the third anniversary of the date of grant. /s/ Lauren Luptak, as Attorney-in-Fact 2024-02-08